This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Topadur Pharma Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Hermann Tenor: Innovator in Pharmaceutical Chemistry
Introduction
Hermann Tenor is a notable inventor based in Schlieren, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Hermann Tenor holds a patent for a "Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof." This invention relates to specific compounds that can be utilized in treating or preventing diseases that are alleviated by the inhibition of PDE5 in humans and non-human mammals. The patent includes detailed chemical formulas and descriptions of the compounds, highlighting their potential in medical applications.
Career Highlights
Tenor's career is marked by his work at Topadur Pharma AG, where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approach has led to the creation of valuable therapeutic agents that address critical health issues.
Collaborations
Throughout his career, Hermann Tenor has collaborated with esteemed colleagues such as Guido Koch and Reto Naef. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Hermann Tenor's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His work continues to influence the development of new therapeutic solutions.